维普中文期刊产品整合服务
31篇 您的检索式:作者名="Momen MA"
    题名 作者 年代 出处 被引量
1GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
2GLP-1R agonist liraglutide activates cytoprotective pathwaysand improves outcomes after experimental myocardial infarction in mice显示文摘Noyan Ashraf MH Momen MA Ban K 2009J Diabetes2009,58,:1
3GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 0,,04:1
4GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
5Effect of maternal anemia on fetal outcome 显示文摘Akhter S Momen MA Rahman MM 2010Mymensingh Med J2010,19,3:1
6GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
7GLP-1R agonist lira- glutide activates cytoprotestive pathways and improves outcomes after experimental maocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
8GLP1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,:1
9GLP-I R agonist li- raglutide activates eytoprotective pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
10GLP-1R agonist li- raglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
11GLP - 1R agonist liraglutidc activates cytoprotective pathways and improves out- comes after experimental myocardial infarction in mice显示文摘Noyan - Ashraf MH Momen MA Ban K 2009Diabe tes2009,58,4:1
12GLP-1R agonist liraglutide activates cytoproteetive pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
13Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice显示文摘Sauvé M Ban K Momen MA 2010Diabetes2010,59,:1
14GLP-1R agonist liraglu-tide activates cytoprotective pathways and improves outcomes after experi-mental myocardial infarction in mice显示文摘Noyanoyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
15GLP-IR aganist liraglutide activates cytoprotective pathways and improves outcomes af- er experimental myocardial infarction in mice 显示文摘NOYAN-ASHRAF MH MOMEN MA Ban K 2009Diabetes2009,58,4:1
16T- he GLP- 1 R agonist liraglutide activates cytoprotective pathways and improves outcomes following experimental myocardial infarction in mice 显示文摘Noyan - Ashraf MH Momen MA Ban K 2009Diabetes2009,58,:1
17GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘NOYAN-ASHRAF MH MOMEN MA BAN K 2009Diabetes2009,58,4:1
18GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice 显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,4:1
19GLP-1Ragonist liraglutide activates cyto-protective pathways and improves out-comes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabe-tes2009,58,4:1
20GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice显示文摘Noyan-Ashraf MH Momen MA Ban K 2009Diabetes2009,58,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费